Beyond Basic Beta ChannelExpect Pharmaceuticals M&A Activity to Rebound After COVID-19 EasesBy Tom LydonApril 17, 2020
ETF Strategist ChannelA Look at the S&P Sectors from 2019By Canterbury Investment ManagementJanuary 8, 2020
Relative Value ChannelCould Coiled Volatility Suggest A Bigger Stock Move Is Coming?By Ian YoungNovember 11, 2019
Beyond Basic Beta Channel8 ETFs to Capture Opportunities in Healthcare SectorBy Max ChenAugust 22, 2019
Innovative ETFs ChannelAbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFsBy Max ChenJune 25, 2019
Beyond Basic Beta Channel4 ETFs to Consider with Big Pharma on the Senate’s Hot SeatBy Ben HernandezApril 9, 2019
Innovative ETFs ChannelPharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug ResultsBy Max ChenFebruary 28, 2019
